Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Safety and Efficacy of Imatinib in Combination With Artemether and Lumefantrine for Treatment of Uncomplicated Malaria

NCT07559370 is registered in ClinicalTrials.gov with Victoria Biomedical Research Institute as lead sponsor.

NCT NCT07559370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07559370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Safety and Efficacy of Imatinib in Combination With Artemether and Lumefantrine for Treatment of Uncomplicated Malaria
Lead sponsor
Victoria Biomedical Research Institute
Phase
Phase 2
Overall status
Recruiting
Start date
January 20, 2026
Completion date
June 30, 2027
Enrollment
1,116 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria (plasmodium falciparum)